News for Yungjin Pharm. Co., Ltd. (003520.KS)

Published at

Oct 9, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Asthma Treatment Market to Cross ~USD 32 Billion by 2030 | DelveInsight

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are...

NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA 0K9E.L 003520.KS VTRSV VTRS.MX VTRS VRNA VIA.DE UTHR REGN34.SA REGN.MX REGN PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MSB.AX MESO MEOBF LQDA LBPSW LBPS FRPRF DXB.AX DDDD.L AMGN.MX AMGN.BA AMGN AMG.DE ALDX 688336.SS 0R2M.L 064550.KQ

Read more →
Published at

Oct 3, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally,...

ZEG.DE VTRSV VTRS.MX VTRS VIA.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK LQDA LBPSW LBPS FRPRF DDDD.L AZNN.MX AZNCF AZN.L AZN 6MK.DE 0K9E.L 0A4J.L 003520.KS VRNA UTHR REGN34.SA REGN.MX REGN MSB.AX MESO MEOBF DXB.AX AMGN.MX AMGN.BA AMGN AMG.DE ALDX ABBV34.SA ABBV.MX ABBV.BA ABBV 688336.SS 4AB.DE 0R2M.L 064550.KQ

Read more →
Published at

Jun 25, 2024 7:00 PM

by globenewswire.com

mixed

mixed

PDE4 Inhibitor Market to Exhibit Substantial Growth Rate During the Study Period (2020–2034) | DelveInsight

The PDE4 inhibitor market is poised for substantial growth in the coming years, driven by expanding research in inflammatory and autoimmune diseases. With...

VRNA VCNX SUNPHARMA-BL.NS SEEL ORYZF ORYN.MX ORY.MC LLY.MX LLY.DE LLY.BA LLY LILY34.SA IONS.MX IONS ANVS ALEC 0RDB.L 0Q1G.L 0JDI.L 003520.KS UTHR SUNPHARMA.NS PRTA JNJ DNLI DJNJ3.BA DJNJ2.BA BIVI 0Y3M.L 064550.KQ

Read more →
Published at

Apr 25, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sa

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly attributed to the increasing...

VRNA LBPSW LBPS FRPRF DDDD.L 003520.KS UTHR PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MSB.AX MRKD.BA MRK.SN MRK.PA MRK.MX MRK MESO MEOBF GSK.L GSK GS7.DE GRFS GRFPN.MX GRF.MC GLAXF GIKLY GIFOF GIFLF DNPUF ALDX 6MK.DE 688336.SS 4506.T 064550.KQ CAHD.BA

Read more →
Published at

Dec 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Autoimmune Diseases Diagnostics Global Market to Surpass 6 Billion Mark by 2028 | DelveInsight

The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...

SUNPHARMA.NS CPHRF CPH.TO 039200.KQ XGN SUNPHARMA-BL.NS MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA GXE.DE GRFS GRFPN.MX GRF.MC GLPGF GLPG.AS GLPG GILDD.BA GIKLY GIFOF GIFLF BBI ABTCL.SN ABT.SN ABT 0Q1G.L 003520.KS LH.MX LH L1CA34.SA HMGN DSRLF DIA.MI ABCZF ABCM ABC.L 0JSY.L

Read more →
Published at

Oct 10, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight

The emergence of new products in the pipeline will add to the musculoskeletal pain market growth in the future. In addition, persistently rising cases of...

CPHRF CPH.TO 039200.KQ MYMD GXE.DE GLPGF GLPG.AS GLPG GILDD.BA BBI 4548.T 003520.KS SUNPHARMA-BL.NS LLY.MX LLY.DE LLY.BA LLY LILY34.SA 0Q1G.L

Read more →
Published at

Sep 25, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi,

The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing to the improvement in the diagnosis...

LBPSW LBPS FRPRF DXB.AX DDDD.L 003520.KS VRNA UTHR MSB.AX MESO MEOBF ALDX 688336.SS 064550.KQ

Read more →
Published at

Sep 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Novartis, GlaxoSmithKline, Roche, BMS, TearSolutions, I

Sjogren's syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GXE.DE GLPGF GLPG.AS GLPG GILDD.BA CPHRF CPH.TO 0Q1G.L 0J9P.L 039200.KQ NKTR MYMD BIOCON.NS BIOCON.BO BBI 0UNL.L 003520.KS

Read more →
Published at

Sep 13, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out - MediciNova, Mesoblast, Veru, Pluristem, Avalo, Boehringer Ingelh

The acute respiratory distress syndrome market size shall grow during the forecast period (2023–2032) owing to the launch of upcoming therapies and is...

VRNA LBPSW LBPS FRPRF DDDD.L 2181.HK 003520.KS UTHR 064550.KQ VERU MSB.AX MESO MEOBF LGVN AVTX

Read more →
Published at

Jul 6, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Anti-Inflammatory Drugs Global Market to Accelerate at a CAGR of ~6% by 2028 | DelveInsight

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

UCBJY UCBJF SUNPHARMA-BL.NS SNCPF PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ GLAXF DJNJ3.BA DJNJ2.BA CPHRF CPH.TO AMGN.MX AMGN.BA AMGN AMG.DE 600276.SS 0K9E.L 039200.KQ STAR.NS STAR.BO SNNAQ SILO RKT.L RBN.MX RBGPF RBGLY RB.L MYMD MRKD.BA MRK.SN MRK.PA MRK.MX MRK MEOBF LLY.MX LLY.DE LLY.BA LLY LILY34.SA IVBXF GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF CTAGY CTAGF BRM.DE BONS.TA BMYB34.SA BMY.MX BMY.BA BMY BBIXF BBI AZNCF ASZP ABBV34.SA ABBV.MX ABBV.BA ABBV 6MK.DE 4AB.DE 3RB.DE 0Q1G.L 003520.KS HRTX 0J4V.L

Read more →
Published at

Jul 26, 2022 5:30 PM

by prnewswire.com

mixed

mixed

New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight

/PRNewswire/ -- DelveInsight's 'Rheumatoid Arthritis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

IDP.DE CPHRF CPH.TO BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB 688177.SS 039200.KQ MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA LBPSW LBPS LABP GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF DDDD.L BBI 0Q1G.L 003520.KS

Read more →